<?xml version="1.0" encoding="UTF-8"?>
<p>Surveillance drug resistance mutations (SDRMs) were examined according to the Stanford Genotypic Resistance calibrated population resistance (CPR) tool version 6.0 based on the WHO surveillance transmitted drug resistance mutation list of 2009 [
 <xref rid="pone.0205446.ref035" ref-type="bibr">35</xref>, 
 <xref rid="pone.0205446.ref036" ref-type="bibr">36</xref>]. Classification of TDR level (low: &lt; 5%, moderate: 5â€“15%, or high: &gt;15%) was made based on the WHO threshold survey protocol [
 <xref rid="pone.0205446.ref020" ref-type="bibr">20</xref>].
</p>
